StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)

Close on Nov 17, 2026Market cap $58.19MP/E –Yield –

PharmaCyte Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

PharmaCyte Biotech's market cap was $4.28M on Nov 11, 2026, against $5.26M a year earlier. Over the last 5 years it ranged from $3.24M to $62.67M, with a median of $16.70M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.28M-19.3%
2025Dec 31, 2025$5.31M-51.9%
2024Dec 31, 2024$11.04M-41.2%
2023Dec 29, 2023$18.79M-67.2%
2022Dec 30, 2022$57.21M+10.5%
2021Dec 31, 2021$51.79M+220.4%
2020Dec 31, 2020$16.16M-71.0%
2019Dec 31, 2019$55.74M+34.8%
2018Dec 31, 2018$41.35M-26.3%
2017Dec 29, 2017$56.11M-57.1%
2016Dec 30, 2016$130.65M+267.7%
2015Dec 31, 2015$35.53M-72.6%
2014Dec 31, 2014$129.48M+108.8%
2013Dec 31, 2013$62.02M–

More PharmaCyte Biotech figures

See a number that looks wrong?